
TY  - JOUR
AU  - Alvarez, Ofelia A.
AU  - Zimmerman, Grenith
TI  - Pegaspargase-induced pancreatitis
JO  - Medical and Pediatric Oncology
JA  - Med. Pediatr. Oncol.
VL  - 34
IS  - 3
SN  - 0098-1532
UR  - https://doi.org/10.1002/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T
DO  - doi:10.1002/(SICI)1096-911X(200003)34:3<200::AID-MPO7>3.0.CO;2-T
SP  - 200
EP  - 205
KW  - pegaspargase - PEG - L-asparaginase
KW  - L-asparaginase
KW  - pancreatitis
KW  - childhood leukemia
PY  - 2000
AB  - Abstract Background The purpose of this study is to report the incidence of pancreatitis in patients treated with pegaspargase in our hospital during a 2-year period. Procedure We identified episodes of pancreatitis related to the intramuscular administration of pegaspargase 2,500 IU/m2 for the treatment of childhood hematological malignancies during a 2-year period (May 1996?April 1998). Patients were evaluated clinically and by sequential serum amylase and lipase determinations and radiographic examinations. For comparison, episodes of pancreatitis in patients who only received native Escherichia coli L-asparaginase were examined during the same time period. Results Nine children with acute lymphoblastic leukemia (ALL) of 50 (18%) patients who received pegaspargase were diagnosed to have pancreatitis. All had prior therapy with native L-asparaginase. These children developed symptoms consisting of abdominal pain, nausea, vomiting, and decreased appetite within a median of 15 days from the onset of pegaspargase administration. Six patients became symptomatic after their initial dose. Seven patients developed severe or unacceptable toxicity (grades 3 and 4), measured by increased amylase (>2 times normal) and lipase levels or radiographic evidence of pancreatic inflammation or pseudocyst. One patient also developed hyperammonemia and encephalopathy. In contrast, only one out of 52 (1.9%) ALL patients who received native E. coli L-asparaginase during the same time period developed pancreatitis (P= 0.007). Conclusion Clinicians should be aware of a possible higher incidence of pancreatitis associated with pegaspargase. Med Pediatr Oncol 34:200?205, 2000. ? 2000 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - 45th Annual Meeting of the Child Neurology Society
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 80
IS  - s20
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.24756
DO  - doi:10.1002/ana.24756
SP  - S267
EP  - S432
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster session abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 18
IS  - S10
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.1950180707
DO  - doi:10.1002/ppul.1950180707
SP  - 179
EP  - 305
PY  - 1994
ER  - 

TY  - JOUR
TI  - ePoster Sessions
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 25
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13699
DO  - doi:10.1111/ene.13699
SP  - 90
EP  - 276
PY  - 2018
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 13
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.12993
DO  - doi:10.1111/jth.12993
SP  - 1
EP  - 997
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Session
JO  - European Journal of Neurology
JA  - Eur J Neurol
VL  - 23
IS  - S2
SN  - 1351-5101
UR  - https://doi.org/10.1111/ene.13091
DO  - doi:10.1111/ene.13091
SP  - 21
EP  - 110
PY  - 2016
ER  - 

TY  - JOUR
TI  - Monday, 25 July 2011
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_1.x
DO  - doi:10.1111/j.1538-7836.2011.04380_1.x
SP  - 1
EP  - 250
PY  - 2011
ER  - 

TY  - JOUR
TI  - Short Submitted Peer Reviewed Abstracts
JO  - Oral Diseases
VL  - 16
IS  - 6
SN  - 1354-523X
UR  - https://doi.org/10.1111/j.1601-0825.2010.01743.x
DO  - doi:10.1111/j.1601-0825.2010.01743.x
SP  - 516
EP  - 572
PY  - 2010
ER  - 

TY  - JOUR
TI  - Medical Topics
JO  - Haemophilia
VL  - 14
IS  - s2
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2008.01725.x
DO  - doi:10.1111/j.1365-2516.2008.01725.x
SP  - 1
EP  - 119
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 14
IS  - S1
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.13325
DO  - doi:10.1111/jth.13325
SP  - 1
EP  - 168
PY  - 2016
ER  - 

TY  - JOUR
TI  - ABSTRACTS OF THE XXIV CONGRESS OF THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 11
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.12284
DO  - doi:10.1111/jth.12284
SP  - 1
EP  - 1322
PY  - 2013
ER  - 

TY  - JOUR
TI  - INTERNATIONAL SPINE INTERVENTION SOCIETY – 2011 19TH ANNUAL SCIENTIFIC MEETING RESEARCH ABSTRACTS
JO  - Pain Medicine
VL  - 12
IS  - 9
SN  - 1526-2375
UR  - https://doi.org/10.1111/j.1526-4637.2011.01225.x
DO  - doi:10.1111/j.1526-4637.2011.01225.x
SP  - 1439
EP  - 1447
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 31
IS  - S2
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.26688
DO  - doi:10.1002/mds.26688
SP  - S1
EP  - S697
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200990184
DO  - doi:10.1002/eji.200990184
SP  - S332
EP  - S555
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - 2009 Meeting of the Peripheral Nerve Society July 4—8, 2009 Würzburg, Germany
JO  - Journal of the Peripheral Nervous System
VL  - 14
IS  - s2
SN  - 1085-9489
UR  - https://doi.org/10.1111/j.1529-8027.2009.00212.x
DO  - doi:10.1111/j.1529-8027.2009.00212.x
SP  - 1
EP  - 163
PY  - 2009
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 10
IS  - s3
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2004.0902c.x
DO  - doi:10.1111/j.1469-0691.2004.0902c.x
SP  - 179
EP  - 273
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 165
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.12802
DO  - doi:10.1111/bjh.12802
SP  - 1
EP  - 103
PY  - 2014
ER  - 

TY  - JOUR
TI  - Posters Session 1, Sunday 18 September
JO  - European Journal of Neurology
VL  - 12
IS  - s2
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2005.01308.x
DO  - doi:10.1111/j.1468-1331.2005.01308.x
SP  - 37
EP  - 300
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts of the 20th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management. Bordeaux, France, 22 - 25 August, 2004
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidem. Drug Safe.
VL  - 13
IS  - S1
SN  - 1053-8569
UR  - https://doi.org/10.1002/pds.987
DO  - doi:10.1002/pds.987
SP  - S1
EP  - S349
PY  - 2004
ER  - 

TY  - JOUR
AU  - Byrne, Mary W.
TI  - Sensory processing disorder: Any of a nurse practitioner's business?
JO  - Journal of the American Academy of Nurse Practitioners
VL  - 21
IS  - 6
SN  - 1041-2972
UR  - https://doi.org/10.1111/j.1745-7599.2009.00417.x
DO  - doi:10.1111/j.1745-7599.2009.00417.x
SP  - 314
EP  - 321
KW  - Sensory processing disorder
KW  - sensory integration
KW  - interdisciplinary treatment
KW  - differential diagnosis
PY  - 2009
AB  - Abstract Purpose: Children who exhibit the confusing symptom patterns associated with sensory processing deficits are often seen first by primary care providers, including family and pediatric nurse practitioners (NPs). The purpose of this article is to alert NPs to the state of the science for these disorders and to the roles NPs could play in filling the knowledge gaps in assessment, treatment, education, and research. Data sources: Literature searches using PubMed and MedLine databases and clinical practice observations. Conclusions: Sensory integration disorders have only begun to be defined during the past 35 years. They are not currently included in the DSM IV standard terminology, and are not yet substantively incorporated into most health disciplines? curricula or practice, including those of the NP. Implications for practice: NPs are in a unique position to test hypothesized terminology for Sensory Processing Disorder (SPD) by contributing precise clinical descriptions of children who match as well as deviate from the criteria for three proposed diagnostic groups: Sensory Modulation Disorder (SMD), Sensory Discrimination Disorder (SDD), and Sensory-Based Motor Disorder (SBMD). Beyond the SPD diagnostic debate, for children with sensory deficit patterns the NP role can incorporate participating in interdisciplinary treatment plans, refining differential diagnoses, providing frontline referral and support for affected children and their families, and making both secondary prevention and critical causal research possible through validation of consistently accepted diagnostic criteria.
ER  - 
